Breaking News Instant updates and real-time market news.

2023-02-08 08:43:43 MYNA Mynaric $4.52 / -0.07 (-1.53%) , TSAT Telesat Holdings $9.01 / +0.01 (+0.11%) 08:43 02/08/23 02/08 08:43 02/08/23 08:43	Mynaric delivers CONDOR Mk2terminals to Telesat Government Solutions Mynaric (MYNA) announced the delivery of multiple CONDOR Mk2 optical communications terminals to Telesat Government Solutions, a wholly-owned U.S.-based subsidiary of leading satellite operator Telesat (TSAT). Mynaric's first delivery of flight-ready CONDOR optical communications terminals for space applications marks an important milestone towards the product family's space flight heritage. Next, the terminals will be mounted to the Croupier satellites as part of the Defense Advanced Research Projects Agency's Blackjack Track B program and subsequently launched to space to commence the mission's operations. MYNA Mynaric $4.52 / -0.07 (-1.53%) TSAT Telesat Holdings $9.01 / +0.01 (+0.11%)

2023-02-08 08:43:43

MYNA

Mynaric

$4.52 / -0.07 (-1.53%)

, TSAT

Telesat Holdings

$9.01 / +0.01 (+0.11%)

08:43

02/08/23

02/08

08:43

02/08/23

08:43

Mynaric delivers CONDOR Mk2terminals to Telesat Government Solutions

Mynaric (MYNA) announced the delivery of multiple CONDOR Mk2 optical communications terminals to Telesat Government Solutions, a wholly-owned U.S.-based subsidiary of leading satellite operator Telesat (TSAT). Mynaric's first delivery of flight-ready CONDOR optical communications terminals for space applications marks an important milestone towards the product family's space flight heritage. Next, the terminals will be mounted to the Croupier satellites as part of the Defense Advanced Research Projects Agency's Blackjack Track B program and subsequently launched to space to commence the mission's operations.

MYNA

Mynaric

$4.52 / -0.07 (-1.53%)

TSAT

Telesat Holdings

$9.01 / +0.01 (+0.11%)

OTHER BREAKING NEWS FROM THE FLY

General news	2-year note auction » 13:09 03/27/23 03/27 13:09 03/27/23 13:09 $ECON Economic Data / + Total Amount: $42B, Rate:… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly Technical Analysis $ECON Economic Data / + 03/22/23 Senators Scott, Warren unveil bipartisan Fed oversight legislation 03/01/23 Einhorn says investors should be 'bearish on stocks and bullish on inflation' $ECON Economic Data / + $ECON Economic Data / + 03/08/23 Biden to propose 25% billionaire tax, Bloomberg says 03/08/23 Biden to propose 25% billionaire tax, Bloomberg says 03/07/23 Powell tells Congress data from January partly reversed softening trends 01/30/23 Fed likely to raise funds rate benchmark by quarter percentage point, WSJ says $ECON Economic Data / + 03/22/23 What You Missed On Wall Street On Wednesday 03/21/23 What You Missed On Wall Street On Tuesday 03/21/23 What You Missed On Wall Street This Morning 03/08/23 What You Missed On Wall Street On Wednesday $ECON Economic Data / + 03/22/23 Fed says 'additional policy firming may be appropriate'
Hot Stocks	Nano Dimension files lawsuit against Murchinson, Anson and Boothbay » 13:08 03/27/23 03/27 13:08 03/27/23 13:08 NNDM Nano Dimension $2.60 / +0.01 (+0.39%) Nano Dimension has filed… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options NNDM Nano Dimension $2.60 / +0.01 (+0.39%) 10:06 Today Nano Dimension announces purchase order from Fraunhofer Institue 03/23/23 Nano Dimension to review options relative to Stratasys and alternative targets 03/23/23 Nano Dimension releases video on products, materials, technologies 03/22/23 Stratasys board unanimously rejects acquisition proposal from Nano Dimension NNDM Nano Dimension $2.60 / +0.01 (+0.39%) 03/10/23 Lake Street Nano Dimension made 'lowball offer' Stratasys won't accept, says Lake Street NNDM Nano Dimension $2.60 / +0.01 (+0.39%) 01/24/23 Nano Dimension reports Q4 revenue $12.1M, up 61% vs. 4Q21 12/01/22 Nano Dimension reports Q3 EPS (26c) vs. (7c) last year 10/24/22 Nano Dimension sees Q3 revenue $10M NNDM Nano Dimension $2.60 / +0.01 (+0.39%) 03/07/23 Nano Dimension receives purchase order for DragonFly IV system NNDM Nano Dimension $2.60 / +0.01 (+0.39%) 03/24/23 What You Missed On Wall Street On Friday 03/24/23 What You Missed On Wall Street This Morning 03/20/23 Fly Intel: After-Hours Movers 03/14/23 What You Missed On Wall Street On Tuesday 03/30/23 Nano Dimension - NNDM NNDM Nano Dimension $2.60 / +0.01 (+0.39%) 03/07/23 Unusually active option classes on open March 7th 01/20/23 Largest borrow rate increases among liquid names
Upgrade	Novartis upgraded to Hold at Deutsche Bank after Kisqali's 'positive surprise' » 13:07 03/27/23 03/27 13:07 03/27/23 13:07 NVS Novartis $90.14 / +6.555 (+7.84%) Deutsche Bank upgraded… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NVS Novartis $90.14 / +6.555 (+7.84%) 12:00 Today Novartis rises 7.5% 06:46 Today Novartis says Kisqali Phase 3 NATALEE trial met primary endpoint at interim 03/24/23 23andMe pilots program to raise awareness about Lipoprotein(a) 03/21/23 Novartis alpelisib granted FDA orphan designation NVS Novartis $90.14 / +6.555 (+7.84%) 12:59 Today Deutsche Bank Novartis upgraded to Hold from Sell at Deutsche Bank 07:24 Today BofA Novartis' NATALEE readout a 'best case scenario,' says BofA 07:18 Today Morgan Stanley Morgan Stanley expects Novartis to outperform after Kisqali 'positive surprise' 01/26/23 Citi Novartis downgraded to Neutral from Buy at Citi NVS Novartis $90.14 / +6.555 (+7.84%) 02/01/23 Novartis sees core operating income to grow mid single digit percentage in 2023 02/01/23 Novartis reports Q4 core EPS $1.52, consensus $1.44 10/25/22 Novartis confirms mid single digit sales, core operating income guidance 10/25/22 Novartis reports Q3 core EPS $1.58 vs. $1.71 last year NVS Novartis $90.14 / +6.555 (+7.84%) 03/22/23 Novartis halts Leqvio heart attack prevention trial, Reuters reports 02/08/23 Avrobio exploring potential sale after approach, Street Insider says 12/29/22 Novartis to pay $245M to settle lawsuit on Exforge medicine, Bloomberg reports 11/16/22 Novartis exploring sale of ophthalmology, respiratory units, Bloomberg says NVS Novartis $90.14 / +6.555 (+7.84%) 03/22/23 What You Missed On Wall Street On Wednesday 03/22/23 What You Missed On Wall Street This Morning 02/10/23 Biotech Alert: Searches spiking for these stocks today 02/01/23 What You Missed On Wall Street This Morning NVS Novartis $90.14 / +6.555 (+7.84%) 01/09/23 Novartis call volume above normal and directionally bullish 12/16/22 Novartis call volume above normal and directionally bullish 10/06/22 Novartis put volume heavy and directionally bearish
Conference/Events	Compass Pathways management to meet virtually with Cantor Fitzgerald » 13:06 03/27/23 03/27 13:06 03/27/23 13:06 CMPS Compass Pathways $10.28 / +0.26 (+2.59%) Virtual Meetings to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events CMPS Compass Pathways $10.28 / +0.26 (+2.59%) 02/28/23 Compass Pathways sees 2023 net cash use $85M-$110M 01/26/23 Cathie Wood's ARK Investment bought 120.3K shares of Compass Pathways today 01/19/23 Cathie Wood's ARK Investment bought 158.2K shares of Compass Pathways today 01/18/23 Cathie Wood's ARK Investment bought 156.6K shares of Compass Pathways today CMPS Compass Pathways $10.28 / +0.26 (+2.59%) 01/09/23 Loop Capital Atai Life Sciences price target lowered to $10 from $18 at Loop Capital 12/15/22 EF Hutton Compass Pathways initiated with a Buy at EF Hutton 12/09/22 Oppenheimer Compass Pathways price target lowered to $33 from $55 at Oppenheimer 11/01/22 Loop Capital Compass Pathways initiated with a Buy at Loop Capital CMPS Compass Pathways $10.28 / +0.26 (+2.59%) 02/28/23 Compass Pathways reports Q4 EPS (73c), consensus (59c) 11/03/22 Compass Pathways reports Q3 EPS (43c), consensus (65c) CMPS Compass Pathways $10.28 / +0.26 (+2.59%) 01/03/23 Oregon becomes first U.S. state to legalize 'magic' mushrooms, NYT says CMPS Compass Pathways $10.28 / +0.26 (+2.59%) 03/23/23 Here's What You Missed in Cannabis, Psychedelics This Week 03/16/23 Rising High: Exclusive talk with house of brands Carma HoldCo 03/09/23 Rising High: Exclusive talk with cannabinoid market research firm BDSA 03/02/23 Rising High: Exclusive talk with vertically-integrated MSO Greenlight 03/29/23 Compass Pathways 03/30/23 Compass Pathways
Options	PVH Corp. options imply 5.1% move in share price post-earnings » 13:04 03/27/23 03/27 13:04 03/27/23 13:04 PVH PVH Corp. $73.70 / +0.795 (+1.09%) Pre-earnings options… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events PVH PVH Corp. $73.70 / +0.795 (+1.09%) 03/08/23 PVH Corp. names Amber McCann Chief Communications Office 12/01/22 PVH Corp. rises 10.2% 12/01/22 PVH Corp. rises 10.5% 11/30/22 PVH Corp. jumps 9% to $73.38 after Q3 earnings beat, guidance raise PVH PVH Corp. $73.70 / +0.795 (+1.09%) 03/21/23 UBS PVH Corp. price target lowered to $92 from $100 at UBS 03/20/23 Goldman Sachs PVH Corp. price target raised to $74 from $67 at Goldman Sachs 02/15/23 Wells Fargo PVH Corp. price target raised to $110 from $85 at Wells Fargo 01/23/23 JPMorgan PVH Corp. price target raised to $95 from $77 at JPMorgan PVH PVH Corp. $73.70 / +0.795 (+1.09%) 11/30/22 PVH Corp. raises FY22 EPS view to $8.25 from $8, consensus $7.89 11/30/22 PVH Corp. sees Q4 adjusted EPS $1.65, consensus $1.70 11/30/22 PVH Corp. reports Q3 adjusted EPS $2.60, consensus $2.15 11/30/22 Notable companies reporting after market close PVH PVH Corp. $73.70 / +0.795 (+1.09%) 12/01/22 What You Missed On Wall Street On Thursday 12/01/22 What You Missed On Wall Street This Morning 12/01/22 Fly Intel: Pre-market Movers 11/30/22 Fly Intel: After-Hours Movers 03/28/23 PVH Corp. - PVH
Hot Stocks	CN, Trealmont, Kaptan plan for new Calgary intermodal transload facility » 13:02 03/27/23 03/27 13:02 03/27/23 13:02 CNI Canadian National $114.65 / +0.95 (+0.84%) CN, Trealmont Transport… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events CNI Canadian National $114.65 / +0.95 (+0.84%) 03/22/23 North American rail traffic down 6.9% for the week ending March 18 03/20/23 Canadian National, Unifor reach tentative agreements 03/15/23 North American rail traffic down 6.1% for the week ending March 11 03/08/23 North American rail traffic down 4.4% for the week ending March 4 CNI Canadian National $114.65 / +0.95 (+0.84%) 07:12 Today BofA Canadian National price target lowered to $134 from $137 at BofA 01/25/23 Desjardins Canadian National price target lowered to C$179 from C$180 at Desjardins 01/25/23 CIBC Canadian National price target lowered to C$175 from C$181 at CIBC 01/25/23 BMO Capital Canadian National price target lowered to C$180 from C$185 at BMO Capital CNI Canadian National $114.65 / +0.95 (+0.84%) 01/24/23 Canadian National reports Q4 EPS C$2.10, consensus C$2.08 10/25/22 Canadian National raises FY22 adjusted EPS view to up 25% from up 15%-20% 10/25/22 Canadian National reports Q3 adjusted EPS C$2.13 vs. C$2.37 last year CNI Canadian National $114.65 / +0.95 (+0.84%) 03/07/23 Ohio crash highlights gap in federal safety regulations, NY Times reports 03/03/23 Norfolk Southern, railroads to join close-call reporting system, WSJ reports 12/01/22 Senate approves bill to force tentative rail labor agreement, CNBC says 11/30/22 House passes bill to avoid rail strike, NBC News reports CNI Canadian National $114.65 / +0.95 (+0.84%) 01/24/23 Fly Intel: After-Hours Movers 11/30/22 What You Missed On Wall Street On Wednesday 11/29/22 What You Missed On Wall Street On Tuesday 11/29/22 What You Missed On Wall Street This Morning 04/24/23 Canadian National - CNI
Upgrade	Novartis upgraded to Hold from Sell at Deutsche Bank » 12:59 03/27/23 03/27 12:59 03/27/23 12:59 NVS Novartis $90.21 / +6.625 (+7.93%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NVS Novartis $90.21 / +6.625 (+7.93%) 12:00 Today Novartis rises 7.5% 06:46 Today Novartis says Kisqali Phase 3 NATALEE trial met primary endpoint at interim 03/24/23 23andMe pilots program to raise awareness about Lipoprotein(a) 03/21/23 Novartis alpelisib granted FDA orphan designation NVS Novartis $90.21 / +6.625 (+7.93%) 07:24 Today BofA Novartis' NATALEE readout a 'best case scenario,' says BofA 07:18 Today Morgan Stanley Morgan Stanley expects Novartis to outperform after Kisqali 'positive surprise' 01/26/23 Citi Novartis downgraded to Neutral from Buy at Citi 01/24/23 Lake Street Harrow Health price target raised to $24 from $17 at Lake Street NVS Novartis $90.21 / +6.625 (+7.93%) 02/01/23 Novartis sees core operating income to grow mid single digit percentage in 2023 02/01/23 Novartis reports Q4 core EPS $1.52, consensus $1.44 10/25/22 Novartis confirms mid single digit sales, core operating income guidance 10/25/22 Novartis reports Q3 core EPS $1.58 vs. $1.71 last year NVS Novartis $90.21 / +6.625 (+7.93%) 03/22/23 Novartis halts Leqvio heart attack prevention trial, Reuters reports 02/08/23 Avrobio exploring potential sale after approach, Street Insider says 12/29/22 Novartis to pay $245M to settle lawsuit on Exforge medicine, Bloomberg reports 11/16/22 Novartis exploring sale of ophthalmology, respiratory units, Bloomberg says NVS Novartis $90.21 / +6.625 (+7.93%) 03/22/23 What You Missed On Wall Street On Wednesday 03/22/23 What You Missed On Wall Street This Morning 02/10/23 Biotech Alert: Searches spiking for these stocks today 02/01/23 What You Missed On Wall Street This Morning NVS Novartis $90.21 / +6.625 (+7.93%) 01/09/23 Novartis call volume above normal and directionally bullish 12/16/22 Novartis call volume above normal and directionally bullish 10/06/22 Novartis put volume heavy and directionally bearish
Hot Stocks	BioMarin granted orphan status for DMD treatment » 12:58 03/27/23 03/27 12:58 03/27/23 12:58 BMRN BioMarin $91.67 / +0.985 (+1.09%) The FDA granted BioMarin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events BMRN BioMarin $91.67 / +0.985 (+1.09%) 03/07/23 BioMarin: FDA accepts sNDA to expand use of VOXZOGO for injection 03/06/23 BioMarin says FDA extends review of BLA for Roctavian 01/08/23 BioMarin announces data from follow up from Phase 3 GENEr8-1 study of ROCTAVIAN 01/03/23 BioMarin's application for Voxzogo in achondroplasia validated by EMA BMRN BioMarin $91.67 / +0.985 (+1.09%) 03/21/23 Bernstein BioMarin initiated with an Underperform at Bernstein 03/09/23 Chardan Tenaya Therapeutics price target lowered to $24 from $28 at Chardan 02/28/23 Stifel BioMarin price target raised to $118 from $114 at Stifel 02/28/23 Wedbush BioMarin price target lowered to $74 from $83 at Wedbush BMRN BioMarin $91.67 / +0.985 (+1.09%) 02/27/23 BioMarin sees FY23 EPS under new method of $1.80-$2.05, consensus $1.61 02/27/23 BioMarin reports Q4 EPS (0c), consensus (7c) 02/27/23 Notable companies reporting after market close 10/26/22 BioMarin backs FY22 revenue view $2.06B-$2.16B, consensus $2.12B BMRN BioMarin $91.67 / +0.985 (+1.09%) 03/24/23 Buy/Sell: Wall Street's top 10 stock calls this week 03/21/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/22/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/21/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/30/23 PDUFA Date for Roctavian--Extended 10/21/23 PDUFA Date for VOXZOGO
Hot Stocks	Incyte granted orphan status for myelofibrosis treatment » 12:57 03/27/23 03/27 12:57 03/27/23 12:57 INCY Incyte $70.82 / +0.59 (+0.84%) The FDA granted Incyte… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options INCY Incyte $70.82 / +0.59 (+0.84%) 05:20 Today Incyte announces Japanese MHLW approval of Pemazyre 03/23/23 Incyte provides regulatory update on Ruxolitinib extended relief 03/22/23 MacroGenics to receive $15M milestone following FDA approval of Zynyz 03/22/23 Incyte announces FDA accelerated approval of Zynyz INCY Incyte $70.82 / +0.59 (+0.84%) 03/24/23 SVB Securities Incyte upgraded to Market Perform at SVB after ruxolitinib XR CRL, Zynz approval 03/24/23 SVB Securities Incyte upgraded to Market Perform from Underperform at SVB Securities 03/24/23 BofA BofA sees minimal near-term impact on Incyte from ruxolitinib ER CRL 02/08/23 Cowen Incyte price target raised to $100 from $95 at Cowen INCY Incyte $70.82 / +0.59 (+0.84%) 02/07/23 Incyte reports Q4 EPS 62c, consensus 58c 02/06/23 Notable companies reporting before tomorrow's open 02/06/23 Notable companies reporting before tomorrow's open 11/01/22 Incyte reports Q3 EPS 60c, consensus 72c INCY Incyte $70.82 / +0.59 (+0.84%) 01/31/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/10/23 Incyte 04/11/23 Incyte INCY Incyte $70.82 / +0.59 (+0.84%) 11/01/22 Early notable gainers among liquid option names on November 1st
Hot Stocks	Centene appoints Tanya McNally as Chief People Officer » 12:49 03/27/23 03/27 12:49 03/27/23 12:49 CNC Centene $64.58 / +0.545 (+0.85%) Centene announced the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CNC Centene $64.58 / +0.545 (+0.85%) 02/08/23 California AG announces $215M settlement against Centene 02/02/23 Managed care stocks pressured after CMS' preliminary Medicare Advantage rates 01/23/23 Centene completes divestiture of Magellan Specialty Health to Evolent Health 01/03/23 Centene's Health Net selected for new medi-cal direct contracts CNC Centene $64.58 / +0.545 (+0.85%) 03/21/23 Wells Fargo Molina Healthcare price target lowered to $282 from $307 at Wells Fargo 03/21/23 Wells Fargo Centene price target lowered to $71 from $79 at Wells Fargo 03/08/23 Deutsche Bank Centene downgraded to Hold on estimate risk at Deutsche Bank 03/08/23 Deutsche Bank Centene downgraded to Hold from Buy at Deutsche Bank CNC Centene $64.58 / +0.545 (+0.85%) 02/07/23 Centene backs FY23 adjusted EPS view $6.25-$6.40, consensus $6.36 02/07/23 Centene reports Q4 EPS 86c, consensus 85c 02/06/23 Notable companies reporting before tomorrow's open 02/06/23 Notable companies reporting before tomorrow's open CNC Centene $64.58 / +0.545 (+0.85%) 11/29/22 Managed care company returns will be tough to keep replicating, WSJ says CNC Centene $64.58 / +0.545 (+0.85%) 03/08/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/23/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/03/23 What You Missed On Wall Street On Tuesday 01/03/23 What You Missed On Wall Street This Morning 04/25/23 Centene - CNC 05/10/23 Centene Corp. CNC Centene $64.58 / +0.545 (+0.85%) 01/17/23 Centene call volume above normal and directionally bullish 01/09/23 Centene put volume heavy and directionally bearish 12/22/22 Early notable gainers among liquid option names on December 22nd 11/21/22 Centene put volume heavy and directionally bearish

Hot Stocks	Kludein I Acquisition Corp trading resumes 12:43 03/27/23 03/27 12:43 03/27/23 12:43 NIR Near Intelligence $6.20 / -6.15 (-49.80%) ShowHide Related Items >><< Company News NIR Near Intelligence $6.20 / -6.15 (-49.80%) 12:38 Today Kludein I Acquisition Corp trading halted, volatility trading pause 03/23/23 Near Intelligence completes business combination, to trade on Nasdaq
Conference/Events	Payoneer Global management to meet with Cantor Fitzgerald » 12:40 03/27/23 03/27 12:40 03/27/23 12:40 PAYO Payoneer Global $6.06 / +0.015 (+0.25%) Group luncheon meeting… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options PAYO Payoneer Global $6.06 / +0.015 (+0.25%) 03/10/23 Payoneer says less than $20M of cash balances held at SVB 02/28/23 Payoneer Global appoints John Caplan as CEO, effective March 1 02/17/23 Payoneer Global receives UK E-Money license from Financial Conduct Authority 01/18/23 Payoneer appoints Ordonez as deputy CFO PAYO Payoneer Global $6.06 / +0.015 (+0.25%) 02/27/23 Jefferies Payoneer Global initiated with a Buy at Jefferies 01/11/23 Wolfe Research Payoneer Global initiated with an Outperform at Wolfe Research 12/30/22 Northland Payoneer Global named a top pick for 2023 at Northland 11/10/22 Citi Payoneer Global price target raised to $10 from $9 at Citi PAYO Payoneer Global $6.06 / +0.015 (+0.25%) 02/28/23 Payoneer Global sees FY23 revenue $800M-$810M, consensus $738.4M 02/28/23 Payoneer Global reports Q4 EPS (3c), consensus (5c) 11/09/22 Payoneer Global sees FY22 revenue $605M-$615M, consensus $598.11M 11/09/22 Payoneer Global reports Q3 EPS (8c), consensus (2c) PAYO Payoneer Global $6.06 / +0.015 (+0.25%) 02/28/23 Fly Intel: After-Hours Movers 10/10/22 What You Missed On Wall Street On Monday 10/10/22 What You Missed On Wall Street This Morning 10/07/22 What You Missed On Wall Street On Friday 03/29/23 Payoneer Global PAYO Payoneer Global $6.06 / +0.015 (+0.25%) 11/16/22 Payoneer Global call volume above normal and directionally bullish
Hot Stocks	Kludein I Acquisition Corp trading halted, volatility trading pause 12:38 03/27/23 03/27 12:38 03/27/23 12:38 NIR Near Intelligence $6.20 / -6.15 (-49.80%) ShowHide Related Items >><< Company News NIR Near Intelligence $6.20 / -6.15 (-49.80%) 03/23/23 Near Intelligence completes business combination, to trade on Nasdaq
Downgrade	Jounce Therapeutics downgraded to Neutral from Overweight at Piper Sandler » 12:37 03/27/23 03/27 12:37 03/27/23 12:37 JNCE Jounce Therapeutics $1.86 / +0.35 (+23.26%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly JNCE Jounce Therapeutics $1.86 / +0.35 (+23.26%) 09:50 Today Jounce Therapeutics trading resumes 09:04 Today Jounce Therapeutics implements workforce reduction of 84% of employees 09:03 Today Jounce to be acquired by Concentra for $1.85 in cash per share plus CVR 08:55 Today Jounce Therapeutics trading halted, news pending JNCE Jounce Therapeutics $1.86 / +0.35 (+23.26%) 02/24/23 SMBC Nikko Jounce Therapeutics downgraded to Neutral from Outperform at SMBC Nikko 02/23/23 Raymond James Jounce downgraded to Market Perform from Outperform at Raymond James 01/02/23 Piper Sandler Piper Sandler keeps Overweight on Jounce Therapeutics, lowers price target to $5 11/11/22 Raymond James Raymond James downgrades Jounce to Outperform on ILT inhibitor data JNCE Jounce Therapeutics $1.86 / +0.35 (+23.26%) 11/10/22 Jounce Therapeutics reports Q3 EPS (60c), consensus (64c) JNCE Jounce Therapeutics $1.86 / +0.35 (+23.26%) 12:04 Today What You Missed On Wall Street This Morning 03/16/23 Biotech Alert: Searches spiking for these stocks today 12/30/22 Biotech Alert: Searches spiking for these stocks today 12/28/22 What You Missed On Wall Street On Wednesday
Conference/Events	Haynes management to meet virtually with Benchmark » 12:25 03/27/23 03/27 12:25 03/27/23 12:25 HAYN Haynes $48.55 / +1.05 (+2.21%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings On The Fly Events HAYN Haynes $48.55 / +1.05 (+2.21%) 02/16/23 Noble Capital Haynes initiated with an Outperform at Noble Capital 11/15/22 KeyBanc Haynes downgraded to Sector Weight from Overweight at KeyBanc 07/08/22 KeyBanc KeyBanc cuts price targets on aerospace materials sub-sector 04/01/22 KeyBanc Haynes price target raised to $55 from $41 at KeyBanc HAYN Haynes $48.55 / +1.05 (+2.21%) 02/02/23 Haynes reports Q1 EPS 67c, consensus 66c 11/17/22 Haynes sees Q1 EPS 55c-70c, consensus 96c 11/17/22 Haynes reports Q4 EPS $1.30, consensus $1.28 HAYN Haynes $48.55 / +1.05 (+2.21%) 02/16/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 13:00 Today Haynes
Recommendations	JPMorgan strategist says Q1 likely high point for equities this year » 12:24 03/27/23 03/27 12:24 03/27/23 12:24 $ECON Economic Data / + , SPX S&P 500 / + , SPY SPDR S&P 500 ETF Trust $395.73 / +0.005 (+0.00%) JPMorgan's Global… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly Options Technical Analysis $ECON SPX SPY $ECON Economic Data / + 03/22/23 Senators Scott, Warren unveil bipartisan Fed oversight legislation 03/01/23 Einhorn says investors should be 'bearish on stocks and bullish on inflation' SPX S&P 500 / + 03/22/23 Senators Scott, Warren unveil bipartisan Fed oversight legislation 03/01/23 Einhorn says not invested long in artificial intelligence companies 03/01/23 Einhorn says investors should be 'bearish on stocks and bullish on inflation' 12/14/22 SEC proposes rules to enhance competition for retail order flow execution SPY SPDR S&P 500 ETF Trust $395.73 / +0.005 (+0.00%) 03/22/23 Senators Scott, Warren unveil bipartisan Fed oversight legislation 03/01/23 Einhorn says not invested long in artificial intelligence companies 03/01/23 Einhorn says investors should be 'bearish on stocks and bullish on inflation' 12/14/22 SEC proposes rules to enhance competition for retail order flow execution $ECON SPX SPY $ECON Economic Data / + SPX S&P 500 / + SPY SPDR S&P 500 ETF Trust $395.73 / +0.005 (+0.00%) $ECON SPX SPY $ECON Economic Data / + 03/08/23 Biden to propose 25% billionaire tax, Bloomberg says 03/08/23 Biden to propose 25% billionaire tax, Bloomberg says 03/07/23 Powell tells Congress data from January partly reversed softening trends 01/30/23 Fed likely to raise funds rate benchmark by quarter percentage point, WSJ says SPX S&P 500 / + 03/20/23 Treasury considering expanding FDIC coverage to all deposits, Bloomberg reports 03/14/23 Fed may extend tougher capital restrictions to midsize banks, WSJ says 03/08/23 Biden to propose 25% billionaire tax, Bloomberg says 03/08/23 Biden to propose 25% billionaire tax, Bloomberg says SPY SPDR S&P 500 ETF Trust $395.73 / +0.005 (+0.00%) 03/20/23 Treasury considering expanding FDIC coverage to all deposits, Bloomberg reports 03/14/23 Fed may extend tougher capital restrictions to midsize banks, WSJ says 03/08/23 Biden to propose 25% billionaire tax, Bloomberg says 03/08/23 Biden to propose 25% billionaire tax, Bloomberg says $ECON SPX SPY $ECON Economic Data / + 03/22/23 What You Missed On Wall Street On Wednesday 03/21/23 What You Missed On Wall Street On Tuesday 03/21/23 What You Missed On Wall Street This Morning 03/08/23 What You Missed On Wall Street On Wednesday SPX S&P 500 / + 03/22/23 What You Missed On Wall Street On Wednesday 03/21/23 What You Missed On Wall Street On Tuesday 03/21/23 What You Missed On Wall Street This Morning 03/17/23 What You Missed On Wall Street On Friday SPY SPDR S&P 500 ETF Trust $395.73 / +0.005 (+0.00%) 03/22/23 What You Missed On Wall Street On Wednesday 03/21/23 What You Missed On Wall Street On Tuesday 03/17/23 What You Missed On Wall Street On Friday 03/08/23 What You Missed On Wall Street On Wednesday SPX SPX S&P 500 / + 03/24/23 SPX options flow afternoon update $ECON SPX SPY $ECON Economic Data / + 03/22/23 Fed says 'additional policy firming may be appropriate' SPX S&P 500 / + 03/22/23 Fed says 'additional policy firming may be appropriate' SPY SPDR S&P 500 ETF Trust $395.73 / +0.005 (+0.00%) 08:24 Today SPDR S&P 500 ETF Trust: Pivot points 03/24/23 SPDR S&P 500 ETF Trust: Pivot points 03/23/23 SPDR S&P 500 ETF Trust: Pivot points 03/22/23 Fed says 'additional policy firming may be appropriate'
Recommendations	Vislink price target lowered to $1 from $1.25 at Alliance Global Partners » 12:19 03/27/23 03/27 12:19 03/27/23 12:19 VISL Vislink / + Alliance Global Partners… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events VISL Vislink / + 01/04/23 Vislink receives over $2M in new airborne downlink orders from U.S., Canada VISL Vislink / + 11/15/22 Alliance Global Partners Vislink price target lowered to $1.25 from $1.75 at Alliance Global Partners VISL Vislink / + 07:34 Today Vislink reports preliminary FY22 EPS (29c) vs (38c) last year 08:30 Today Vislink - VISL
Technical Analysis	NASDAQ market internals summary » 12:17 03/27/23 03/27 12:17 03/27/23 12:17 $NSD NASDAQ Market Internals / + Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals / + 11:17 Today NASDAQ market internals summary 10:17 Today NASDAQ market internals summary 03/24/23 NASDAQ market internals summary 03/24/23 NASDAQ market internals summary
General news	Fed's Barr repeated the line that the banking system is "sound and resilient," » 12:15 03/27/23 03/27 12:15 03/27/23 12:15 $ECON Economic Data / + Fed's Barr repeated… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly Technical Analysis $ECON Economic Data / + 03/22/23 Senators Scott, Warren unveil bipartisan Fed oversight legislation 03/01/23 Einhorn says investors should be 'bearish on stocks and bullish on inflation' $ECON Economic Data / + $ECON Economic Data / + 03/08/23 Biden to propose 25% billionaire tax, Bloomberg says 03/08/23 Biden to propose 25% billionaire tax, Bloomberg says 03/07/23 Powell tells Congress data from January partly reversed softening trends 01/30/23 Fed likely to raise funds rate benchmark by quarter percentage point, WSJ says $ECON Economic Data / + 03/22/23 What You Missed On Wall Street On Wednesday 03/21/23 What You Missed On Wall Street On Tuesday 03/21/23 What You Missed On Wall Street This Morning 03/08/23 What You Missed On Wall Street On Wednesday $ECON Economic Data / + 03/22/23 Fed says 'additional policy firming may be appropriate'
Recommendations	Farmers Edge price target lowered to C$0.30 from C$0.45 at Raymond James » 12:14 03/27/23 03/27 12:14 03/27/23 12:14 FMEGF Farmers Edge / + Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research FMEGF Farmers Edge / + 03/17/23 Canaccord Farmers Edge price target lowered to C$0.25 from C$0.40 at Canaccord 01/26/23 National Bank Farmers Edge price target lowered to C$0.25 from C$0.30 at National Bank 11/16/22 Canaccord Farmers Edge price target lowered to C$0.40 from C$1 at Canaccord 10/20/22 National Bank Farmers Edge price target lowered to C$0.50 from C$1 at National Bank

Recommendations	Knight Therapeutics price target lowered to C$6.50 from C$7.50 at RBC Capital » 12:13 03/27/23 03/27 12:13 03/27/23 12:13 KHTRF Knight Therapeutics $3.47 / -0.1065 (-2.98%) RBC Capital lowered the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings KHTRF Knight Therapeutics $3.47 / -0.1065 (-2.98%) 12/23/22 Knight Therapeutics closes $38.5M loan with IFC 12/01/22 Knight Therapeutics announces relaunch of AKYNZEO in Canada KHTRF Knight Therapeutics $3.47 / -0.1065 (-2.98%) 04:24 Today National Bank Knight Therapeutics downgraded to Sector Perform at National Bank 08/12/22 Stifel Knight Therapeutics price target raised to C$5.40 from C$5.30 at Stifel 05/13/22 Canaccord Knight Therapeutics price target lowered to C$6.75 from C$7 at Canaccord KHTRF Knight Therapeutics $3.47 / -0.1065 (-2.98%) 03/23/23 Knight Therapeutics sees 2023 revenue C$280M-C$300M 03/23/23 Knight Therapeutics reports Q4 EPS (C$0.13) vs. (C$0.07) last year 11/10/22 Knight Therapeutics sees 2022 revenue C$265M-C$275M 11/10/22 Knight Therapeutics reports Q3 EPS C$0.01 vs. (C$0.07) last year
Recommendations	Patriot Battery Metals price target raised to C$16.75 from C$16.50 at Canaccord » 12:12 03/27/23 03/27 12:12 03/27/23 12:12 PMETF Patriot Battery Metals $8.35 / +0.126 (+1.53%) Canaccord analyst Katie… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research PMETF Patriot Battery Metals $8.35 / +0.126 (+1.53%) 03/23/23 Patriot Battery Metals provides update on drill campaign at Corvette property 01/30/23 Patriot Battery Metals announces core assay results holes at CV5 Pegmatite 01/23/23 Patriot Battery Metals appoints Natacha Garoute as CFO 12/08/22 OTC Markets Group welcomes Patriot Battery Metals to OTCQX PMETF Patriot Battery Metals $8.35 / +0.126 (+1.53%) 02/28/23 Stifel Patriot Battery Metals price target raised to C$16 from C$8.25 at Stifel 02/01/23 Canaccord Patriot Battery Metals price target raised to C$16.50 from C$9.75 at Canaccord 11/30/22 Stifel Patriot Battery Metals initiated with a Speculative Buy at Stifel 10/17/22 Canaccord Patriot Battery Metals initiated with a Speculative Buy at Canaccord
Recommendations	Osisko Gold price target raised to C$25.50 from C$23 at Canaccord » 12:10 03/27/23 03/27 12:10 03/27/23 12:10 OR Osisko Gold $15.04 / +0.03 (+0.20%) Canaccord analyst Carey… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research OR Osisko Gold $15.04 / +0.03 (+0.20%) 02/24/23 Falco Resources extends certain deadlines under silver stream transaction 01/10/23 Osisko reports preliminary Q4 revenue for royalties, streams C$61.9M 12/28/22 Osisko Gold updates on CSA mine in NSW, Australia 12/08/22 Osisko Gold announces TSX approval to renew normal course issuer bid OR Osisko Gold $15.04 / +0.03 (+0.20%) 07:44 Today Canaccord Osisko Gold price target raised to C$25.50 from C$23 at Canaccord 03/01/23 TD Securities Osisko Gold price target lowered to C$22 from C$24 at TD Securities 02/27/23 Raymond James Osisko Gold price target lowered to C$22 from C$22.50 at Raymond James 02/15/23 BMO Capital Osisko Gold price target raised to C$21 from C$18 at BMO Capital
Recommendations	Hammond Power Solutions price target raised to C$41.50 from C$29 at Canaccord » 12:10 03/27/23 03/27 12:10 03/27/23 12:10 HMDPF Hammond Power Solutions $25.72 / -0.0287 (-0.11%) Canaccord raised the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research HMDPF Hammond Power Solutions $25.72 / -0.0287 (-0.11%) 10/31/22 Canaccord Hammond Power Solutions price target raised to C$29 from C$22 at Canaccord 10/28/22 Canaccord Hammond Power Solutions price target raised to C$29 from C$22 at Canaccord 04/13/22 Canaccord Hammond Power Solutions initiated with a Buy at Canaccord
Recommendations	Copperleaf Technologies price target raised to C$6.25 from C$5.50 at Canaccord » 12:09 03/27/23 03/27 12:09 03/27/23 12:09 CPLFF Copperleaf Technologies $3.77 / + (+0.00%) Canaccord analyst Robert… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research CPLFF Copperleaf Technologies $3.77 / + (+0.00%) 03/24/23 BMO Capital Copperleaf Technologies price target lowered to C$6.50 from C$7 at BMO Capital 03/24/23 RBC Capital Copperleaf Technologies price target lowered to C$7 from C$8 at RBC Capital 03/24/23 Canaccord Copperleaf Technologies price target raised to C$6.25 from C$5.50 at Canaccord 11/14/22 RBC Capital Copperleaf Technologies price target lowered to C$8 from C$10 at RBC Capital